AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 116 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $14,017,000 | -25.8% | 499,000 | 0.0% | 0.46% | -19.3% |
Q2 2019 | $18,892,000 | -3.0% | 499,000 | 0.0% | 0.57% | -14.3% |
Q1 2019 | $19,471,000 | +232.1% | 499,000 | +81.5% | 0.67% | +157.7% |
Q4 2018 | $5,863,000 | -46.1% | 275,000 | 0.0% | 0.26% | -35.0% |
Q3 2018 | $10,887,000 | +3.6% | 275,000 | 0.0% | 0.40% | -8.3% |
Q2 2018 | $10,508,000 | +29.5% | 275,000 | +1.9% | 0.44% | +14.7% |
Q1 2018 | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
Q4 2017 | $7,031,000 | +11.6% | 225,000 | 0.0% | 0.37% | +2.8% |
Q3 2017 | $6,302,000 | +46.4% | 225,000 | 0.0% | 0.36% | +33.2% |
Q2 2017 | $4,304,000 | +12.3% | 225,000 | 0.0% | 0.27% | +5.5% |
Q1 2017 | $3,834,000 | -6.7% | 225,000 | 0.0% | 0.25% | -4.9% |
Q4 2016 | $4,111,000 | +2.6% | 225,000 | 0.0% | 0.27% | +9.0% |
Q3 2016 | $4,007,000 | – | 225,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |